Details for Patent: 8,420,592
✉ Email this page to a colleague
Which drugs does patent 8,420,592 protect, and when does it expire?
Patent 8,420,592 protects KIMYRSA and ORBACTIV and is included in two NDAs.
This patent has twenty patent family members in fifteen countries.
Summary for Patent: 8,420,592
| Title: | Methods of treatment using single doses of oritavancin |
| Abstract: | Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against a wide range of bacteria. Methods for the treatment, prophylaxis and prevention of bacterial infection and disease in animals, including humans, using a single dose of oritavancin over the course of therapy, are described. |
| Inventor(s): | Lehoux; Dario (Terrebonne, CA), Parr; Thomas R. (Indianapolis, IN), Moeck; Gregory (St. Laurent, CA), Etienne; Pierre (Montreal, CA) |
| Assignee: | The Medicines Company (Parsippany, NJ) |
| Application Number: | 13/060,811 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 8,420,592
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Melinta Therap | KIMYRSA | oritavancin diphosphate | POWDER;INTRAVENOUS | 214155-001 | Mar 12, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS WITH A SINGLE DOSE OF 1200MG ORITAVANCIN OR ITS SINGLE DOSE EQUIVALENT | ⤷ Sign Up | ||||
| Melinta Therap | ORBACTIV | oritavancin diphosphate | POWDER;INTRAVENOUS | 206334-001 | Aug 6, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS USING A SINGLE DOSE | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,420,592
| PCT Information | |||
| PCT Filed | August 29, 2009 | PCT Application Number: | PCT/US2009/055466 |
| PCT Publication Date: | March 04, 2010 | PCT Publication Number: | WO2010/025438 |
International Family Members for US Patent 8,420,592
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2337575 | ⤷ Sign Up | 300834 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2337575 | ⤷ Sign Up | CA 2016 00044 | Denmark | ⤷ Sign Up |
| European Patent Office | 2337575 | ⤷ Sign Up | 41/2016 | Austria | ⤷ Sign Up |
| European Patent Office | 2337575 | ⤷ Sign Up | 122016000075 | Germany | ⤷ Sign Up |
| European Patent Office | 2337575 | ⤷ Sign Up | 1690041-7 | Sweden | ⤷ Sign Up |
| European Patent Office | 2337575 | ⤷ Sign Up | 2016/040 | Ireland | ⤷ Sign Up |
| European Patent Office | 2337575 | ⤷ Sign Up | 16C0039 | France | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
